Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation
Background: Elevated expression of focal adhesion kinase (FAK) occurs in numerous human cancers including colon-, cervix- and breast cancer. Although several studies have implicated FAK in mammary tumour formation induced by ectopic oncogene expression, evidence supporting a role for FAK in spontane...
Gespeichert in:
Veröffentlicht in: | British journal of cancer 2014-05, Vol.110 (11), p.2747-2755 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2755 |
---|---|
container_issue | 11 |
container_start_page | 2747 |
container_title | British journal of cancer |
container_volume | 110 |
creator | van Miltenburg, M H A M van Nimwegen, M J Tijdens, I Lalai, R Kuiper, R Klarenbeek, S Schouten, P C de Vries, A Jonkers, J van de Water, B |
description | Background:
Elevated expression of focal adhesion kinase (FAK) occurs in numerous human cancers including colon-, cervix- and breast cancer. Although several studies have implicated FAK in mammary tumour formation induced by ectopic oncogene expression, evidence supporting a role for FAK in spontaneous mammary tumour development caused by loss of tumour suppressor genes such as p53 is lacking. Alterations in the tumour suppressor gene p53 have been implicated in over 50% of human breast cancers. Given that elevated FAK expression highly correlates with p53 mutation status in human breast cancer, we set out to investigate the importance of FAK in p53-mediated spontaneous mammary tumour development.
Methods:
To directly assess the role of FAK, we generated mice with conditional inactivation of FAK and p53. We generated female p53
lox/lox
/FAK
+/+
/WapCre, p53
lox/lox
/FAK
flox/+
/WapCre and p53
lox/lox
/FAK
flox/−
/WapCre mice, and mice with WapCre-mediated conditional expression of p53
R270H
, the mouse equivalent of human p53
R273H
hot spot mutation, together with conditional deletion of FAK, P53
R270H/+
/FAK
lox/+
/WapCre and p53
R270H/+
/FAK
flox/−
/WapCre mice. All mice were subjected to one pregnancy to induce WapCre-mediated deletion of
p53
or expression of p53 R270H, and
Fak
genes flanked by two loxP sites, and subsequently followed the development of mammary tumours.
Results:
Using this approach, we show that FAK is important for p53-induced mammary tumour development. In addition, mice with the mammary gland-specific conditional expression of p53 point mutation R270H, the mouse equivalent to human R273H, in combination with conditional deletion of
Fak
showed reduced incidence of p53
R270H
-induced mammary tumours. In both models these effects of FAK were related to reduced proliferation in preneoplastic lesions in the mammary gland ductal structures.
Conclusions:
Mammary gland-specific ablation of FAK hampers p53-regulated spontaneous mammary tumour formation. Focal adhesion kinase deletion reduced proliferative capacity of p53 null and p53
R270H
mammary epithelial cells but did not lead to increased apoptosis
in vivo
. Our data identify FAK as an important regulator in mammary epithelial cell proliferation in p53-mediated and p53
R270H
-induced mammary tumour development. |
doi_str_mv | 10.1038/bjc.2014.219 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4037829</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3316537201</sourcerecordid><originalsourceid>FETCH-LOGICAL-c513t-e4cd90877301e91c1259f4bdaa224ae1310e92b56abee7d6ada1b7a07b0e439e3</originalsourceid><addsrcrecordid>eNptkUuLFDEUhYMoTtu6cy0FIriw2ryqU9kMyOALRtzoOtxKbnWnrUebVCn-e2_Z7TiKq5Dcj5Nz7mHsseAbwVX9sjn4jeRCb6Swd9hKVEqWopbmLltxzk3JreQX7EHOB7paXpv77ELqmltTqxX7_gH6HtKPYtfBEMp8RB_b6AtoOpjiOBRjW7Sjh66AsMe8vHyJA2QsEobZYy6mPRZx8DHg4HHBj5UqewwRJgxFf5af5n6cE0ml_pfuQ3avhS7jo_O5Zp_fvP509a68_vj2_dWr69JXQk0lah8Wz0ZxgVZ4ISvb6iYASKkBhRIcrWyqLTSIJmwhgGgMcNNw1MqiWrPLk-5xbsiUx2FK0LljiostN0J0f0-GuHe78ZvTXJlaWhJ4fhZI49cZ8-T6mD12tC4c5-xEpTUtVlWa0Kf_oAfKPFA8omRtDTemIurFifJpzDlhe2NGcLc06qhRtzTqqFHCn9wOcAP_rpCAZ2cAMvXUJqAy8h-uroTZErhm5YnLNBp2mG65-9_HPwHgdLoq</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1528970775</pqid></control><display><type>article</type><title>Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation</title><source>MEDLINE</source><source>Nature</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>van Miltenburg, M H A M ; van Nimwegen, M J ; Tijdens, I ; Lalai, R ; Kuiper, R ; Klarenbeek, S ; Schouten, P C ; de Vries, A ; Jonkers, J ; van de Water, B</creator><creatorcontrib>van Miltenburg, M H A M ; van Nimwegen, M J ; Tijdens, I ; Lalai, R ; Kuiper, R ; Klarenbeek, S ; Schouten, P C ; de Vries, A ; Jonkers, J ; van de Water, B</creatorcontrib><description>Background:
Elevated expression of focal adhesion kinase (FAK) occurs in numerous human cancers including colon-, cervix- and breast cancer. Although several studies have implicated FAK in mammary tumour formation induced by ectopic oncogene expression, evidence supporting a role for FAK in spontaneous mammary tumour development caused by loss of tumour suppressor genes such as p53 is lacking. Alterations in the tumour suppressor gene p53 have been implicated in over 50% of human breast cancers. Given that elevated FAK expression highly correlates with p53 mutation status in human breast cancer, we set out to investigate the importance of FAK in p53-mediated spontaneous mammary tumour development.
Methods:
To directly assess the role of FAK, we generated mice with conditional inactivation of FAK and p53. We generated female p53
lox/lox
/FAK
+/+
/WapCre, p53
lox/lox
/FAK
flox/+
/WapCre and p53
lox/lox
/FAK
flox/−
/WapCre mice, and mice with WapCre-mediated conditional expression of p53
R270H
, the mouse equivalent of human p53
R273H
hot spot mutation, together with conditional deletion of FAK, P53
R270H/+
/FAK
lox/+
/WapCre and p53
R270H/+
/FAK
flox/−
/WapCre mice. All mice were subjected to one pregnancy to induce WapCre-mediated deletion of
p53
or expression of p53 R270H, and
Fak
genes flanked by two loxP sites, and subsequently followed the development of mammary tumours.
Results:
Using this approach, we show that FAK is important for p53-induced mammary tumour development. In addition, mice with the mammary gland-specific conditional expression of p53 point mutation R270H, the mouse equivalent to human R273H, in combination with conditional deletion of
Fak
showed reduced incidence of p53
R270H
-induced mammary tumours. In both models these effects of FAK were related to reduced proliferation in preneoplastic lesions in the mammary gland ductal structures.
Conclusions:
Mammary gland-specific ablation of FAK hampers p53-regulated spontaneous mammary tumour formation. Focal adhesion kinase deletion reduced proliferative capacity of p53 null and p53
R270H
mammary epithelial cells but did not lead to increased apoptosis
in vivo
. Our data identify FAK as an important regulator in mammary epithelial cell proliferation in p53-mediated and p53
R270H
-induced mammary tumour development.</description><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/bjc.2014.219</identifier><identifier>PMID: 24809783</identifier><identifier>CODEN: BJCAAI</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/420/755 ; 692/699/67/1347 ; Ablation ; Adhesion ; Animals ; Apoptosis ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Breast cancer ; Cancer Research ; Carcinogenesis - metabolism ; Carcinoma - enzymology ; Carcinoma - genetics ; Carcinoma - pathology ; Carcinosarcoma - enzymology ; Carcinosarcoma - genetics ; Carcinosarcoma - pathology ; Cell Proliferation ; Cervix ; Drug Resistance ; Epidemiology ; Epithelial Cells - enzymology ; Female ; Focal Adhesion Kinase 1 - deficiency ; Focal Adhesion Kinase 1 - genetics ; Genes ; Humans ; Incidence ; Kinases ; Mammary Glands, Animal - enzymology ; Mammary Glands, Animal - pathology ; Mammary Neoplasms, Experimental - enzymology ; Mammary Neoplasms, Experimental - genetics ; Mammary Neoplasms, Experimental - pathology ; Medical research ; Medical sciences ; Mice ; Mice, Inbred C57BL ; Molecular Diagnostics ; Molecular Medicine ; Mutation ; Mutation, Missense ; Oncology ; Toxicology ; Tumor Burden ; Tumor Suppressor Protein p53 - genetics ; Tumor Suppressor Protein p53 - metabolism ; Tumorigenesis ; Tumors</subject><ispartof>British journal of cancer, 2014-05, Vol.110 (11), p.2747-2755</ispartof><rights>The Author(s) 2014</rights><rights>2015 INIST-CNRS</rights><rights>Copyright Nature Publishing Group May 27, 2014</rights><rights>Copyright © 2014 Cancer Research UK 2014 Cancer Research UK</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c513t-e4cd90877301e91c1259f4bdaa224ae1310e92b56abee7d6ada1b7a07b0e439e3</citedby><cites>FETCH-LOGICAL-c513t-e4cd90877301e91c1259f4bdaa224ae1310e92b56abee7d6ada1b7a07b0e439e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037829/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037829/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,729,782,786,887,27933,27934,53800,53802</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28517678$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24809783$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Miltenburg, M H A M</creatorcontrib><creatorcontrib>van Nimwegen, M J</creatorcontrib><creatorcontrib>Tijdens, I</creatorcontrib><creatorcontrib>Lalai, R</creatorcontrib><creatorcontrib>Kuiper, R</creatorcontrib><creatorcontrib>Klarenbeek, S</creatorcontrib><creatorcontrib>Schouten, P C</creatorcontrib><creatorcontrib>de Vries, A</creatorcontrib><creatorcontrib>Jonkers, J</creatorcontrib><creatorcontrib>van de Water, B</creatorcontrib><title>Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><addtitle>Br J Cancer</addtitle><description>Background:
Elevated expression of focal adhesion kinase (FAK) occurs in numerous human cancers including colon-, cervix- and breast cancer. Although several studies have implicated FAK in mammary tumour formation induced by ectopic oncogene expression, evidence supporting a role for FAK in spontaneous mammary tumour development caused by loss of tumour suppressor genes such as p53 is lacking. Alterations in the tumour suppressor gene p53 have been implicated in over 50% of human breast cancers. Given that elevated FAK expression highly correlates with p53 mutation status in human breast cancer, we set out to investigate the importance of FAK in p53-mediated spontaneous mammary tumour development.
Methods:
To directly assess the role of FAK, we generated mice with conditional inactivation of FAK and p53. We generated female p53
lox/lox
/FAK
+/+
/WapCre, p53
lox/lox
/FAK
flox/+
/WapCre and p53
lox/lox
/FAK
flox/−
/WapCre mice, and mice with WapCre-mediated conditional expression of p53
R270H
, the mouse equivalent of human p53
R273H
hot spot mutation, together with conditional deletion of FAK, P53
R270H/+
/FAK
lox/+
/WapCre and p53
R270H/+
/FAK
flox/−
/WapCre mice. All mice were subjected to one pregnancy to induce WapCre-mediated deletion of
p53
or expression of p53 R270H, and
Fak
genes flanked by two loxP sites, and subsequently followed the development of mammary tumours.
Results:
Using this approach, we show that FAK is important for p53-induced mammary tumour development. In addition, mice with the mammary gland-specific conditional expression of p53 point mutation R270H, the mouse equivalent to human R273H, in combination with conditional deletion of
Fak
showed reduced incidence of p53
R270H
-induced mammary tumours. In both models these effects of FAK were related to reduced proliferation in preneoplastic lesions in the mammary gland ductal structures.
Conclusions:
Mammary gland-specific ablation of FAK hampers p53-regulated spontaneous mammary tumour formation. Focal adhesion kinase deletion reduced proliferative capacity of p53 null and p53
R270H
mammary epithelial cells but did not lead to increased apoptosis
in vivo
. Our data identify FAK as an important regulator in mammary epithelial cell proliferation in p53-mediated and p53
R270H
-induced mammary tumour development.</description><subject>692/420/755</subject><subject>692/699/67/1347</subject><subject>Ablation</subject><subject>Adhesion</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Breast cancer</subject><subject>Cancer Research</subject><subject>Carcinogenesis - metabolism</subject><subject>Carcinoma - enzymology</subject><subject>Carcinoma - genetics</subject><subject>Carcinoma - pathology</subject><subject>Carcinosarcoma - enzymology</subject><subject>Carcinosarcoma - genetics</subject><subject>Carcinosarcoma - pathology</subject><subject>Cell Proliferation</subject><subject>Cervix</subject><subject>Drug Resistance</subject><subject>Epidemiology</subject><subject>Epithelial Cells - enzymology</subject><subject>Female</subject><subject>Focal Adhesion Kinase 1 - deficiency</subject><subject>Focal Adhesion Kinase 1 - genetics</subject><subject>Genes</subject><subject>Humans</subject><subject>Incidence</subject><subject>Kinases</subject><subject>Mammary Glands, Animal - enzymology</subject><subject>Mammary Glands, Animal - pathology</subject><subject>Mammary Neoplasms, Experimental - enzymology</subject><subject>Mammary Neoplasms, Experimental - genetics</subject><subject>Mammary Neoplasms, Experimental - pathology</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Molecular Diagnostics</subject><subject>Molecular Medicine</subject><subject>Mutation</subject><subject>Mutation, Missense</subject><subject>Oncology</subject><subject>Toxicology</subject><subject>Tumor Burden</subject><subject>Tumor Suppressor Protein p53 - genetics</subject><subject>Tumor Suppressor Protein p53 - metabolism</subject><subject>Tumorigenesis</subject><subject>Tumors</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNptkUuLFDEUhYMoTtu6cy0FIriw2ryqU9kMyOALRtzoOtxKbnWnrUebVCn-e2_Z7TiKq5Dcj5Nz7mHsseAbwVX9sjn4jeRCb6Swd9hKVEqWopbmLltxzk3JreQX7EHOB7paXpv77ELqmltTqxX7_gH6HtKPYtfBEMp8RB_b6AtoOpjiOBRjW7Sjh66AsMe8vHyJA2QsEobZYy6mPRZx8DHg4HHBj5UqewwRJgxFf5af5n6cE0ml_pfuQ3avhS7jo_O5Zp_fvP509a68_vj2_dWr69JXQk0lah8Wz0ZxgVZ4ISvb6iYASKkBhRIcrWyqLTSIJmwhgGgMcNNw1MqiWrPLk-5xbsiUx2FK0LljiostN0J0f0-GuHe78ZvTXJlaWhJ4fhZI49cZ8-T6mD12tC4c5-xEpTUtVlWa0Kf_oAfKPFA8omRtDTemIurFifJpzDlhe2NGcLc06qhRtzTqqFHCn9wOcAP_rpCAZ2cAMvXUJqAy8h-uroTZErhm5YnLNBp2mG65-9_HPwHgdLoq</recordid><startdate>20140527</startdate><enddate>20140527</enddate><creator>van Miltenburg, M H A M</creator><creator>van Nimwegen, M J</creator><creator>Tijdens, I</creator><creator>Lalai, R</creator><creator>Kuiper, R</creator><creator>Klarenbeek, S</creator><creator>Schouten, P C</creator><creator>de Vries, A</creator><creator>Jonkers, J</creator><creator>van de Water, B</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20140527</creationdate><title>Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation</title><author>van Miltenburg, M H A M ; van Nimwegen, M J ; Tijdens, I ; Lalai, R ; Kuiper, R ; Klarenbeek, S ; Schouten, P C ; de Vries, A ; Jonkers, J ; van de Water, B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c513t-e4cd90877301e91c1259f4bdaa224ae1310e92b56abee7d6ada1b7a07b0e439e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>692/420/755</topic><topic>692/699/67/1347</topic><topic>Ablation</topic><topic>Adhesion</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Breast cancer</topic><topic>Cancer Research</topic><topic>Carcinogenesis - metabolism</topic><topic>Carcinoma - enzymology</topic><topic>Carcinoma - genetics</topic><topic>Carcinoma - pathology</topic><topic>Carcinosarcoma - enzymology</topic><topic>Carcinosarcoma - genetics</topic><topic>Carcinosarcoma - pathology</topic><topic>Cell Proliferation</topic><topic>Cervix</topic><topic>Drug Resistance</topic><topic>Epidemiology</topic><topic>Epithelial Cells - enzymology</topic><topic>Female</topic><topic>Focal Adhesion Kinase 1 - deficiency</topic><topic>Focal Adhesion Kinase 1 - genetics</topic><topic>Genes</topic><topic>Humans</topic><topic>Incidence</topic><topic>Kinases</topic><topic>Mammary Glands, Animal - enzymology</topic><topic>Mammary Glands, Animal - pathology</topic><topic>Mammary Neoplasms, Experimental - enzymology</topic><topic>Mammary Neoplasms, Experimental - genetics</topic><topic>Mammary Neoplasms, Experimental - pathology</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Molecular Diagnostics</topic><topic>Molecular Medicine</topic><topic>Mutation</topic><topic>Mutation, Missense</topic><topic>Oncology</topic><topic>Toxicology</topic><topic>Tumor Burden</topic><topic>Tumor Suppressor Protein p53 - genetics</topic><topic>Tumor Suppressor Protein p53 - metabolism</topic><topic>Tumorigenesis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Miltenburg, M H A M</creatorcontrib><creatorcontrib>van Nimwegen, M J</creatorcontrib><creatorcontrib>Tijdens, I</creatorcontrib><creatorcontrib>Lalai, R</creatorcontrib><creatorcontrib>Kuiper, R</creatorcontrib><creatorcontrib>Klarenbeek, S</creatorcontrib><creatorcontrib>Schouten, P C</creatorcontrib><creatorcontrib>de Vries, A</creatorcontrib><creatorcontrib>Jonkers, J</creatorcontrib><creatorcontrib>van de Water, B</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Miltenburg, M H A M</au><au>van Nimwegen, M J</au><au>Tijdens, I</au><au>Lalai, R</au><au>Kuiper, R</au><au>Klarenbeek, S</au><au>Schouten, P C</au><au>de Vries, A</au><au>Jonkers, J</au><au>van de Water, B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation</atitle><jtitle>British journal of cancer</jtitle><stitle>Br J Cancer</stitle><addtitle>Br J Cancer</addtitle><date>2014-05-27</date><risdate>2014</risdate><volume>110</volume><issue>11</issue><spage>2747</spage><epage>2755</epage><pages>2747-2755</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><coden>BJCAAI</coden><abstract>Background:
Elevated expression of focal adhesion kinase (FAK) occurs in numerous human cancers including colon-, cervix- and breast cancer. Although several studies have implicated FAK in mammary tumour formation induced by ectopic oncogene expression, evidence supporting a role for FAK in spontaneous mammary tumour development caused by loss of tumour suppressor genes such as p53 is lacking. Alterations in the tumour suppressor gene p53 have been implicated in over 50% of human breast cancers. Given that elevated FAK expression highly correlates with p53 mutation status in human breast cancer, we set out to investigate the importance of FAK in p53-mediated spontaneous mammary tumour development.
Methods:
To directly assess the role of FAK, we generated mice with conditional inactivation of FAK and p53. We generated female p53
lox/lox
/FAK
+/+
/WapCre, p53
lox/lox
/FAK
flox/+
/WapCre and p53
lox/lox
/FAK
flox/−
/WapCre mice, and mice with WapCre-mediated conditional expression of p53
R270H
, the mouse equivalent of human p53
R273H
hot spot mutation, together with conditional deletion of FAK, P53
R270H/+
/FAK
lox/+
/WapCre and p53
R270H/+
/FAK
flox/−
/WapCre mice. All mice were subjected to one pregnancy to induce WapCre-mediated deletion of
p53
or expression of p53 R270H, and
Fak
genes flanked by two loxP sites, and subsequently followed the development of mammary tumours.
Results:
Using this approach, we show that FAK is important for p53-induced mammary tumour development. In addition, mice with the mammary gland-specific conditional expression of p53 point mutation R270H, the mouse equivalent to human R273H, in combination with conditional deletion of
Fak
showed reduced incidence of p53
R270H
-induced mammary tumours. In both models these effects of FAK were related to reduced proliferation in preneoplastic lesions in the mammary gland ductal structures.
Conclusions:
Mammary gland-specific ablation of FAK hampers p53-regulated spontaneous mammary tumour formation. Focal adhesion kinase deletion reduced proliferative capacity of p53 null and p53
R270H
mammary epithelial cells but did not lead to increased apoptosis
in vivo
. Our data identify FAK as an important regulator in mammary epithelial cell proliferation in p53-mediated and p53
R270H
-induced mammary tumour development.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>24809783</pmid><doi>10.1038/bjc.2014.219</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-0920 |
ispartof | British journal of cancer, 2014-05, Vol.110 (11), p.2747-2755 |
issn | 0007-0920 1532-1827 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4037829 |
source | MEDLINE; Nature; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | 692/420/755 692/699/67/1347 Ablation Adhesion Animals Apoptosis Biological and medical sciences Biomedical and Life Sciences Biomedicine Breast cancer Cancer Research Carcinogenesis - metabolism Carcinoma - enzymology Carcinoma - genetics Carcinoma - pathology Carcinosarcoma - enzymology Carcinosarcoma - genetics Carcinosarcoma - pathology Cell Proliferation Cervix Drug Resistance Epidemiology Epithelial Cells - enzymology Female Focal Adhesion Kinase 1 - deficiency Focal Adhesion Kinase 1 - genetics Genes Humans Incidence Kinases Mammary Glands, Animal - enzymology Mammary Glands, Animal - pathology Mammary Neoplasms, Experimental - enzymology Mammary Neoplasms, Experimental - genetics Mammary Neoplasms, Experimental - pathology Medical research Medical sciences Mice Mice, Inbred C57BL Molecular Diagnostics Molecular Medicine Mutation Mutation, Missense Oncology Toxicology Tumor Burden Tumor Suppressor Protein p53 - genetics Tumor Suppressor Protein p53 - metabolism Tumorigenesis Tumors |
title | Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T11%3A33%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mammary%20gland-specific%20ablation%20of%20focal%20adhesion%20kinase%20reduces%20the%20incidence%20of%20p53-mediated%20mammary%20tumour%20formation&rft.jtitle=British%20journal%20of%20cancer&rft.au=van%20Miltenburg,%20M%20H%20A%20M&rft.date=2014-05-27&rft.volume=110&rft.issue=11&rft.spage=2747&rft.epage=2755&rft.pages=2747-2755&rft.issn=0007-0920&rft.eissn=1532-1827&rft.coden=BJCAAI&rft_id=info:doi/10.1038/bjc.2014.219&rft_dat=%3Cproquest_pubme%3E3316537201%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1528970775&rft_id=info:pmid/24809783&rfr_iscdi=true |